29:I[587520,["https://cdn.oninvest.com/_next/static/chunks/1f4dcf02c57c6a00.js","https://cdn.oninvest.com/_next/static/chunks/a282554578d34b69.js","https://cdn.oninvest.com/_next/static/chunks/7a2682d3e1f083e4.js","https://cdn.oninvest.com/_next/static/chunks/bbbaa3f15ad3f2c3.js","https://cdn.oninvest.com/_next/static/chunks/6b903eeab812db43.js","https://cdn.oninvest.com/_next/static/chunks/8b78f1bbfe034d67.js","https://cdn.oninvest.com/_next/static/chunks/258bb831f093f894.js","https://cdn.oninvest.com/_next/static/chunks/ca19f4afd9a78812.js","https://cdn.oninvest.com/_next/static/chunks/fec1cad35a691e10.js","https://cdn.oninvest.com/_next/static/chunks/62fb2cb73203c213.js","https://cdn.oninvest.com/_next/static/chunks/08f8af072e766da4.js","https://cdn.oninvest.com/_next/static/chunks/257d907b2f490c09.js"],"default"] 2b:I[27201,["https://cdn.oninvest.com/_next/static/chunks/d96012bcfc98706a.js","https://cdn.oninvest.com/_next/static/chunks/963c71eec1d89c3f.js"],"IconMark"] 2a:T4e1,Last week, Playboy’s pivot toward licensing and lingerie sales began to pay off, while AirSculpt highlighted a potential boost from growing demand for GLP-1-related plastic surgery. In biotech, AbCellera surged on successful trial results for its hot-flash drug, while Sionna cratered after its cystic fibrosis treatment failed in a mid-stage study. Meanwhile, financial services firm Marex Group reached an all-time high after market volatility helped drive a sharp rise in second-quarter revenue and net income. Oninvest recaps these stories from the small-cap space for the week of August 10-14.

AbCellera Biologics Inc. Stocks

In Guru Portfolios